{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:56:31Z","timestamp":1778201791478,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.clnu.2012.06.012","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T17:15:15Z","timestamp":1342890915000},"page":"577-582","source":"Crossref","is-referenced-by-count":44,"title":["The 2011 ESPEN Arvid Wretlind lecture: Cancer cachexia: The potential impact of translational research on patient-focused outcomes"],"prefix":"10.1016","volume":"31","author":[{"given":"K.C.H.","family":"Fearon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2012.06.012_bib1","first-page":"28","article-title":"Malignancy: cancer cachexia","volume":"27","author":"Calman","year":"1982","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.clnu.2012.06.012_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib3","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2007.15.8881","article-title":"Symptom assessment in palliative care: a need for international collaboration","volume":"26","author":"Kaasa","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clnu.2012.06.012_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2012.06.012_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib6","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib7","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Can Res"},{"key":"10.1016\/j.clnu.2012.06.012_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMcibr1106880","article-title":"Cancer cachexia and fat-muscle physiology","volume":"365","author":"Fearon","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2012.06.012_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.clnu.2012.06.012_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnu.2012.06.012_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/bjs.1800840214","article-title":"Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer","volume":"84","author":"Wigmore","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.clnu.2012.06.012_bib12","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9","article-title":"Acute phase protein response and survival duration of patients with pancreatic cancer","volume":"75","author":"Falconer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia-cachexia syndrome","volume":"19","author":"Bennani-Baiti","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000658-198302000-00006","article-title":"Energy expenditure in malnourished cancer patients","volume":"197","author":"Knox","year":"1983","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnu.2012.06.012_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SPC.0b013e32833e4a5d","article-title":"Cytokine gene polymorphism and susceptibility to cachexia","volume":"4","author":"Tan","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2012.06.012_bib16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3945\/ajcn.2008.27025","article-title":"Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastroesophageal malignancy","volume":"89","author":"Deans","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF03256358","article-title":"Interleukin-10 gene polymorphisms influence susceptibility to cachexia in patients with low-third gastric cancer in a Chinese population","volume":"14","author":"Sun","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.clnu.2012.06.012_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/emmm.201200231","article-title":"P-selectin genotype is associated with the development of cancer cachexia","author":"Tan","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clnu.2012.06.012_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clnu.2010.07.012","article-title":"Magnetic resonance imaging with K-means clustering objectively measures whole muscle volume compartments in sarcopenia\/cancer cachexia","volume":"30","author":"Gray","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Stephens","year":"2011","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2012.06.012_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1042\/BST0370981","article-title":"The assembly of lipid droplets and its realtion to cellular insulin sensitvity","volume":"37","author":"Bostrom","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.clnu.2012.06.012_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/gerona\/glp179","article-title":"The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure","volume":"65","author":"Crane","year":"2010","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.clnu.2012.06.012_bib23","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/db10-1221","article-title":"Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained atheletes?","volume":"60","author":"Amati","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2012.06.012_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.clnu.2012.06.012_bib25","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-11-2133","article-title":"Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies","volume":"18","author":"Gallagher","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clnu.2012.06.012_bib26","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2119::AID-CNCR12>3.0.CO;2-1","article-title":"Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients","volume":"78","author":"Palomares","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00520-010-0832-y","article-title":"Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer","volume":"19","author":"Skipworth","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2011.12.008","article-title":"Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function","author":"Stephens","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.clnu.2011.05.010","article-title":"Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring","volume":"30","author":"Skipworth","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.06.012_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2011.06.013","article-title":"Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy?","author":"Ferriolli","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.clnu.2012.06.012_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/HCR.0b013e3182467194","article-title":"Long-term efficacy of pulmonary rehabilitation: a state of the art review","volume":"32","author":"Ochmann","year":"2012","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.clnu.2012.06.012_bib32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","article-title":"Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids","volume":"90","author":"Moses","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","article-title":"A\u00a0prospective randomized study of megestrol acetate and ibuprofen in\u00a0gastrointestinal cancer patients with weigh loss","volume":"79","author":"McMillan","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnu.2012.06.012_bib35","first-page":"259","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in patients with advance malignancy","volume":"2","author":"Greig","year":"2011","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2012.06.012_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561412001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561412001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T08:34:10Z","timestamp":1561970050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561412001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0261561412001355"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2012.06.012","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}